04/25/2024
3:38 PM | Deciphera Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024
3:43 PM | Deciphera Pharmaceuticals (Filer)
| Form ARS | |
04/25/2024
6:10 AM | Deciphera Pharmaceuticals (Filer)
| Form DEF 14A | |
04/24/2024
3:30 PM | Brightstar Associates LLC (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
6:10 AM | Deciphera Pharmaceuticals (Filer)
| Form PRER14A | |
04/11/2024
6:10 AM | Deciphera Pharmaceuticals (Filer)
| Form PRE 14A | |
02/14/2024
1:26 PM | ARMISTICE CAPITAL, LLC (Filed by)
Deciphera Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
02/12/2024
4:32 PM | Deciphera Pharmaceuticals (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
02/09/2024
3:30 PM | Brightstar Associates LLC (Filed by)
Deciphera Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
3:30 PM | Brightstar Associates LLC (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
6:52 AM | Deciphera Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/07/2024
6:11 AM | Deciphera Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/06/2024
3:52 PM | Deciphera Pharmaceuticals (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G/A | |
02/06/2024
6:10 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
8:45 AM | Deciphera Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
3:15 PM | Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:15 PM | Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:15 PM | Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:15 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:15 PM | Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:15 PM | Deciphera Pharmaceuticals (Issuer)
Pitman Jama (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:15 PM | Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:15 PM | Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:14 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
5:05 PM | Deciphera Pharmaceuticals (Subject)
Martin Daniel C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2023
6:06 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
6:11 AM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/05/2023
3:15 PM | Deciphera Pharmaceuticals (Issuer)
Dhanak Dashyant (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/09/2023
6:06 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
6:09 AM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/23/2023
3:05 PM | Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Kelley Susan L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:05 PM | Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:05 PM | Benz Edward J. JR (Reporting)
Deciphera Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Martin John Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:06 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
06/21/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:05 PM | Deciphera Pharmaceuticals (Issuer)
Pitman Jama (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
7:45 AM | Deciphera Pharmaceuticals (Filer)
| Form S-3ASR | |
05/03/2023
6:07 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
6:10 AM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2023
7:05 AM | Deciphera Pharmaceuticals (Filer)
| Form DEF 14A | |
04/26/2023
7:06 AM | Deciphera Pharmaceuticals (Filer)
| Form DEFA14A | |
04/26/2023
7:14 AM | Deciphera Pharmaceuticals (Filer)
| Form ARS | |
